logo

For the Inventor, By the Inventor

Jiangsu, China

Chenyang Wang

This inventor holds 5 USPTO granted patents and 3 EPO patents. Top assignee: Jiangsu Hengrui Medicine Company Ltd.. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chenyang Wang. Retrieved from https://idiyas.com/inventor/chenyang-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 40.0

 

Average Co-Inventor Count = 3.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Jiangsu, CN (2020 - 2021)
  • Lianyungang, CN (2023)

Company Filing History:

goldMedal5 out of 159 
 
Jiangsu Hengrui Medicine Company Ltd.
 patents

Years Active: 2020-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents
1. 11701349 - Pharmaceutical composition containing quinoline derivative (2023-07-18),
2. 11065241 - Pharmaceutical composition comprising quinoline derivative or salt thereof (2021-07-20),
3. 10973807 - Pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound (2021-04-13),
4. 10966964 - Method for preparing pharmaceutical composition comprising pyrrolo-fused six-membered heterocyclic compound (2021-04-06),
5. 10722469 - Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof (2020-07-28),

Title: Chenyang Wang: Innovator in Pharmaceutical Composition

Introduction

Chenyang Wang is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions that enhance drug efficacy. With a total of 5 patents to his name, Wang continues to push the boundaries of pharmaceutical science.

Latest Patents

Wang's latest patents include a pharmaceutical composition containing a quinoline derivative. The first patent describes a composition comprising (R, E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy) phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidinyl-2-yl)-acrylamide or a pharmacologically acceptable salt thereof. This composition is obtained through a series of processes including mixing, granulating, and dynamic drying. The second patent also focuses on a pharmaceutical composition containing a quinoline derivative or a salt thereof, specifically (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-propeneamide. This composition is noted for its rapid dissolution properties.

Career Highlights

Chenyang Wang is currently associated with Jiangsu Hengrui Medicine Company Ltd., a leading pharmaceutical company in China. His work at Hengrui has allowed him to focus on innovative drug formulations that address various medical needs. Wang's expertise in pharmaceutical chemistry has positioned him as a key player in the industry.

Collaborations

Wang collaborates with several talented individuals in his field, including Xinhua Zhang and Yun Lu. These collaborations enhance the research and development efforts at Jiangsu Hengrui Medicine Company Ltd., fostering an environment of innovation and creativity.

Conclusion

Chenyang Wang is a notable inventor whose work in pharmaceutical compositions has the potential to significantly impact the medical field. His innovative approaches and collaborations continue to drive advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…